Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine

Suresh K. Balani, Xin Xu, Byron H. Arison, Maria V. Silva, Amy Gries, Florencia A. DeLuna, Donghui Cui, Prasad H. Kari, Trung Ly, Cornelis E. C. A. Hop, Rominder Singh, Michael A. Wallace, Dennis C. Dean, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
Drug Metabolism and Disposition November 2000, 28 (11) 1274-1278;
Suresh K. Balani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin Xu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Byron H. Arison
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria V. Silva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Gries
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florencia A. DeLuna
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donghui Cui
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prasad H. Kari
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trung Ly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelis E. C. A. Hop
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rominder Singh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Wallace
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis C. Dean
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiunn H. Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul G. Pearson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas A. Baillie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Caspofungin acetate (MK-0991) is a semisynthetic pneumocandin derivative being developed as a parenteral antifungal agent with broad-spectrum activity against systemic infections such as those caused by Candida and Aspergillusspecies. Following a 1-h i.v. infusion of 70 mg of [3H]MK-0991 to healthy subjects, excretion of drug-related material was very slow, such that 41 and 35% of the dosed radioactivity was recovered in urine and feces, respectively, over 27 days. Plasma and urine samples collected around 24 h postdose contained predominantly unchanged MK-0991, together with trace amounts of a peptide hydrolysis product, M0, a linear peptide. However, at later sampling times, M0 proved to be the major circulating component, whereas corresponding urine specimens contained mainly the hydrolytic metabolites M1 and M2, together with M0 and unchanged MK-0991, whose cumulative urinary excretion over the first 16 days postdose represented 13, 71, 1, and 9%, respectively, of the urinary radioactivity. The major metabolite, M2, was highly polar and extremely unstable under acidic conditions when it was converted to a less polar product identified asN-acetyl-4(S)-hydroxy-4-(4-hydroxyphenyl)-l-threonine γ-lactone. Derivatization of M2 in aqueous media led to its identification as the corresponding γ-hydroxy acid,N-acetyl-4(S)-hydroxy-4-(4-hydroxyphenyl)-l-threonine. Metabolite M1, which was extremely polar, eluting from HPLC column just after the void volume, was identified by chemical derivatization as des-acetyl-M2. Thus, the major urinary and plasma metabolites of MK-0991 resulted from peptide hydrolysis and/orN-acetylation.

Footnotes

  • Send reprint requests to: S. K. Balani, DuPont Pharmaceuticals Co., Stine-Haskell Research Center, Bldg. 110, 1090 Elkton Rd., Newark, DE. E-mail: suresh.k.balani{at}dupontpharma.com

  • Abbreviations used are::
    MK-0991
    L-743872, Caspofungin acetate, CANCIDAS, 1-[(4R,5S)-5-[(2-aminoethyl)amino)-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-l-ornithine]-5-[(3R)-3-hydroxy-l-ornithine] pneumocandin B0 diacetate (salt), CAS registry no. 179463-17-3
    MS
    mass spectrometry
    LC
    liquid chromatography
    ACN
    acetonitrile
    TFA
    trifluoroacetic acid
    • Received April 11, 2000.
    • Accepted July 20, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 28 (11)
Drug Metabolism and Disposition
Vol. 28, Issue 11
1 Nov 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine

Suresh K. Balani, Xin Xu, Byron H. Arison, Maria V. Silva, Amy Gries, Florencia A. DeLuna, Donghui Cui, Prasad H. Kari, Trung Ly, Cornelis E. C. A. Hop, Rominder Singh, Michael A. Wallace, Dennis C. Dean, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
Drug Metabolism and Disposition November 1, 2000, 28 (11) 1274-1278;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rapid CommunicationShort Communication

Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine

Suresh K. Balani, Xin Xu, Byron H. Arison, Maria V. Silva, Amy Gries, Florencia A. DeLuna, Donghui Cui, Prasad H. Kari, Trung Ly, Cornelis E. C. A. Hop, Rominder Singh, Michael A. Wallace, Dennis C. Dean, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
Drug Metabolism and Disposition November 1, 2000, 28 (11) 1274-1278;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communication

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics